Lower risk of atopic dermatitis among infants born extremely preterm compared with higher gestational age

British Journal of Dermatology

Volumn 169, Issue 6, 2013, Pages 1257-1264

  Barbarot, S ^a   Gras Leguen, C ^b   Colas, H ^b   Garrot, E ^b   Darmaun, D ^c   Larroque, B ^b,d   Roze, J C ^b   Ancel, P Y ^b,d  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c CEMAGREF   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ALLERGY; ARTICLE; ASSISTED VENTILATION; ATOPIC DERMATITIS; CESAREAN SECTION; COHORT ANALYSIS; CONTROLLED STUDY; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; VERY LOW BIRTH WEIGHT; BIRTH WEIGHT; COMPARATIVE STUDY; DERMATITIS, ATOPIC; EPISODIC MEMORY; NEWBORN; PRESCHOOL CHILD; RISK FACTOR;

BIRTH WEIGHT; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; MALE; MEMORY, EPISODIC; RISK FACTORS;

EID: 84889036490     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12581     Document Type: Article

References (39)

1. Williams HC,. Clinical practice. Atopic dermatitis. N Engl J Med 2005; 352: 2314-24.
2. Chamlin SL, Frieden IJ, Williams ML, Chren MM,. Effects of atopic dermatitis on young American children and their families. Pediatrics 2004; 114: 607-11.
3. Ellis CN, Drake LA, Prendergast MM, et al,. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002; 46: 361-70.
4. Bieber T,. Atopic dermatitis. N Engl J Med 2008; 358: 1483-94.
5. Halken S,. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Pediatr Allergy Immunol 2004; 15 (Suppl. 16): 4-5, 9-32.
6. Gillman MW,. Developmental origins of health and disease. N Engl J Med 2005; 353: 1848-50.
7. Kalia YN, Nonato LB, Lund CH, Guy RH,. Development of skin barrier function in premature infants. J Invest Dermatol 1998; 111: 320-6.
8. Lucas A, Brooke OG, Cole TJ, et al,. Food and drug reactions, wheezing, and eczema in preterm infants. Arch Dis Child 1990; 65: 411-15.
9. Govaere E, Van Gysel D, Verhamme KM, et al,. The prevalence, characteristics of and risk factors for eczema in Belgian schoolchildren. Pediatr Dermatol 2009; 26: 129-38.
10. Buhrer C, Grimmer I, Niggemann B, Obladen M,. Low 1-year prevalence of atopic eczema in very low birthweight infants. Lancet 1999; 353: 1674.
11. David TJ, Ewing CI,. Atopic eczema and preterm birth. Arch Dis Child 1988; 63: 435-6.
12. Lundholm C, Ortqvist AK, Lichtenstein P, et al,. Impaired fetal growth decreases the risk of childhood atopic eczema: a Swedish twin study. Clin Exp Allergy 2010; 40: 1044-53.
13. Kvenshagen B, Jacobsen M, Halvorsen R,. Atopic dermatitis in premature and term children. Arch Dis Child 2009; 94: 202-5.
14. Siltanen M, Kajosaari M, Pohjavuori M, Savilahti E,. Prematurity at birth reduces the long-term risk of atopy. J Allergy Clin Immunol 2001; 107: 229-34.
15. Steffensen FH, Sorensen HT, Gillman MW, et al,. Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology 2000; 11: 185-8.
16. Olesen AB, Ellingsen AR, Olesen H, et al,. Atopic dermatitis and birth factors: historical follow up by record linkage. BMJ 1997; 314: 1003-8.
17. Siltanen M, Wehkalampi K, Hovi P, et al,. Preterm birth reduces the incidence of atopy in adulthood. J Allergy Clin Immunol 2011; 127: 935-42.
18. Pekkanen J, Xu B, Jarvelin MR,. Gestational age and occurrence of atopy at age 31-a prospective birth cohort study in Finland. Clin Exp Allergy 2001; 31: 95-102.
19. Larroque B, Bréart G, Kaminski M, et al,. Survival of very preterm infants: Epipage, a population based cohort study. Arch Dis Child Fetal Neonatal Ed 2004; 89: F139-44.
20. Rozé JC, Bureau-Rouger V, Beucher A, et al,. Follow-up network for newborns at risk for handicap in a French region. Arch Pediatr 2007; 14 (Suppl. 1): S65-70.
21. Marret S, Ancel PY, Marpeau L, et al,. Neonatal and 5-year outcomes after birth at 30-34 weeks of gestation. Obstet Gynecol 2007; 110: 72-80.
22. Fenton TR, Sauve RS,. Using the LMS method to calculate z-scores for the Fenton preterm infant growth chart. Eur J Clin Nutr 2007; 61: 1380-5.
23. Eller E, Kjaer HF, Host A, et al,. Development of atopic dermatitis in the DARC birth cohort. Pediatr Allergy Immunol 2010; 21: 307-14.
24. Jaakkola JJ, Ahmed P, Ieromnimon A, et al,. Preterm delivery and asthma: a systematic review and meta-analysis. J Allergy Clin Immunol 2006; 118: 823-30.
25. Zachariassen G, Faerk J, Esberg BH, et al,. Allergic diseases among very preterm infants according to nutrition after hospital discharge. Pediatr Allergy Immunol 2011; 22: 515-20.
26. Blondel B, Norton J, du Mazaubrun C, Bréart G,. Development of the main indicators of perinatal health in metropolitan France between 1995 and 1998. Results of the national perinatal survey. J Gynecol Obstet Biol Reprod (Paris) 2001; 30: 552-64.
27. Shaw TE, Currie GP, Koudelka CW, Simpson EL,. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011; 131: 67-73.
28. Fleming S, Bodner C, Devereux G, et al,. An application of the United Kingdom Working Party diagnostic criteria for atopic dermatitis in Scottish infants. J Invest Dermatol 2001; 117: 1526-30.
29. Hogewoning AA, Bouwes Bavinck JN, Amoah AS, et al,. Point and period prevalences of eczema in rural and urban schoolchildren in Ghana, Gabon and Rwanda. J Eur Acad Dermatol Venereol 2012; 26: 488-94.
30. Laughter D, Istvan JA, Tofte SJ, Hanifin JM,. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 2000; 43: 649-55.
31. Kramer U, Schafer T, Behrendt H, Ring J,. The influence of cultural and educational factors on the validity of symptom and diagnosis questions for atopic eczema. Br J Dermatol 1998; 139: 1040-6.
32. Irvine AD, McLean WH, Leung DY,. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365: 1315-27.
33. van den Oord RA, Sheikh A,. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009; 339: b2433.
34. Brown SJ, McLean WH,. Eczema genetics: current state of knowledge and future goals. J Invest Dermatol 2009; 129: 543-52.
35. Jutel M, Akdis M, Blaser K, Akdis CA,. Mechanisms of allergen specific immunotherapy-T-cell tolerance and more. Allergy 2006; 61: 796-807.
36. Jacquot A, Neveu D, Aujoulat F, et al,. Dynamics and clinical evolution of bacterial gut microflora in extremely premature patients. J Pediatr 2011; 158: 390-6.
37. Godfrey KM, Barker DJ, Osmond C,. Disproportionate fetal growth and raised IgE concentration in adult life. Clin Exp Allergy 1994; 24: 641-8.
38. Wegmann TG, Lin H, Guilbert L, Mosmann TR,. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14: 353-6.
39. Sherriff A, Golding J,. Hygiene levels in a contemporary population cohort are associated with wheezing and atopic eczema in preschool infants. Arch Dis Child 2002; 87: 26-9.